Green synthesis of ultra-small VOx nanodots for acidic-activated HSP60 inhibition and therapeutic enhancement

Biomaterials. 2019 Feb:194:94-104. doi: 10.1016/j.biomaterials.2018.12.022. Epub 2018 Dec 20.

Abstract

Using metal oxide semiconductor nanomaterials for synergistic cancer treatment has recently attracted the attention of numerous researchers. Herein, oxygen-defective vanadium oxide nanodots (VOx NDs) with ultra-small size and great dispersibility were synthesized via a novel user-friendly method, and then doxorubicin was loaded onto the VOx NDs surfaces. The VOx NDs had great photothermal conversion efficiency and stability. Doxorubicin-loaded VOx NDs can simultaneously serve as therapeutic agent and tumor microenvironment-activable HSP60 inhibitor, resulting in improved efficacy of photothermal therapy and released active doxorubicin for chemotherapy. Finally, we show that synergistic treatment achieved significant therapeutic effects in mice. These results provided a promising strategy for developing novel methods of synthesizing metal oxide semiconductors for enhanced synergistic cancer treatment.

Keywords: Heat shock protein; Photothermal; Synergistic therapy; Vanadium oxide; pH-responsive.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use*
  • Chaperonin 60 / antagonists & inhibitors
  • Chaperonin 60 / metabolism
  • Doxorubicin / therapeutic use*
  • Green Chemistry Technology / methods
  • HCT116 Cells
  • Humans
  • Hyperthermia, Induced / methods
  • Mice
  • Mice, Nude
  • Nanoparticles / therapeutic use*
  • Nanotechnology / methods
  • Neoplasms / metabolism
  • Neoplasms / pathology
  • Neoplasms / therapy*
  • Oxides / therapeutic use
  • Vanadium Compounds / therapeutic use*

Substances

  • Antineoplastic Agents
  • Chaperonin 60
  • Oxides
  • Vanadium Compounds
  • Doxorubicin